Richard B. Lai Fatt
No más puestos en curso
Perfil
Richard B.
Lai Fatt has been Vice President of Corporate Development for Nventa Biopharmaceuticals Corp.
since joining the company in June 2007.
Prior to Nventa Biopharmaceuticals, Dr. Lai Fatt was Vice President of Corporate Development for Kalypsys, Inc. Prior to joining Kalypsys, he was Vice President of Business Development and Strategic Marketing for Isis Pharmaceuticals.
Dr. Lai Fatt held various positions at DuPont Merck Pharmaceuticals, Schering-Plough International, Schering Canada and Lederle Pharmaceuticals.
He received a BS from the University of Miami, Florida and a PhD degree in Biology from McMaster University, Hamilton, Ontario, Canada.
Antiguos cargos conocidos de Richard B. Lai Fatt.
| Empresas | Cargo | Fin |
|---|---|---|
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Corporate Officer/Principal | - |
Formación de Richard B. Lai Fatt.
| University of Miami | Undergraduate Degree |
| McMaster University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Richard B. Lai Fatt
